In 2025, patients and healthcare providers have several viable alternatives to Neurontin for managing epilepsy, neuropathic pain, and other related conditions. This article explores eight alternatives, focusing on their benefits and drawbacks. The information is geared towards aiding informed decisions, highlighting critical aspects of each option. The discussion offers insights into effective management with well-established alternatives.
0 Comments
